An in vitro study of the hydroxyl radical scavenging property of fluvastatin, an HMG-CoA reductase inhibitor

Chemical and Pharmaceutical Bulletin

Volumn 47, Issue 7, 1999, Pages 1010-1012

  Suzumura, Kuniharu ^a   Yasuhara, Mikiko ^a   Tanaka, Keiko ^a   Odawara, Akio ^a   Narita, Hiroshi ^a   Suzuki, Toshikazu ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Antioxidant; Fluvastatin; HMG CoA reductase inhibitor; Hydroxyl radical; Hypolipidemic drug; Radical scavenger

Indexed keywords

ALPHA TOCOPHEROL; DIMETHYLTHIOUREA; FLUINDOSTATIN; HYDROXYL RADICAL; PRAVASTATIN; SCAVENGER; SIMVASTATIN;

ARTICLE; DRUG ACTIVITY; IN VITRO STUDY;

EID: 0032769823     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.47.1010     Document Type: Article

References (20)

1. Holvoet P., Collen D., Atherosclerosis, 137 (suppl.), S33-S38 (1998).
2. Plosker G. L., Wagstaff A. J., Drugs. 51, 433-459 (1996).
3. Goldstein J. L., Ho Y. K. , Basu S. K., Brown M. S., Proc. Natl. Acad. Sci. U.S.A., 76, 333-337 (1979).
4. Kita T., Nagano Y., Yokode M., Ishii K., Kume N., Ooshima A., Yoshida H., Kawai C., Proc. Natl. Acad. Sci. U.S.A., 84, 5928-5931 (1987).
5. Carew T. E., Schwenke D. C., Steinberg D., Proc. Natl. Acad. Sci. U.S.A., 84, 7725-7729 (1987).
6. Daugherty A., Roselaar S. E., Cardiovasc. Res., 29, 297-311 (1995).
7. Hussein O., Schlezinger S., Rosenblat M., Keidar S., Aviram M., Atherosclerosis, 128, 11-18 (1997).
8. Leonhardt W., Kurktschiev T., Meissner D., Lattke P., Abletshauser C., Weidinger G., Jaross W., Hanefeld M., Eur. J. Clin. Pharmacol., 53, 65-69 (1997).
9. Mitani H., Bandoh T., Ishikawa J., Kimura M., Totsuka T., Hayashi S., Brit. J. Pharmacol., 119, 1269-1275 (1996).
10. Smith C., Mitchinson M. J., Aruoma O. I., Halliwell B., Biochem. J., 286, 901-905 (1992).
11. Dain J. G., Fu E., Gorski J., Nicoletti J., Scallen T. J., Drug Metab. Dispos., 21, 567-572 (1993).
12. Russell J., Ness J., Chopra M., Mcmurray J., Smith W. E., J. Pharm. Biomed. Anal., 12, 863-866 (1994).
13. Kagan V. E., Tsuchiya M., Serbinova E., Packer L., Sies H., Biochem. Pharmacol., 45, 393-400 (1993).
14. Steenken S., Sundquist A. R., Jovanovic S. V., Crockett R., Sies H., Chem. Res. Toxicol., 5, 355-360 (1992).
15. Rice-Evance C. A., Miller N. J., Paganga G., Free. Rad. Biol. Med., 20, 933-956 (1996).
16. Umeda T., Hara T., Hayashida M., Niijima T., Cell. Mol. Biol., 31, 229-233 (1985).
17. Balla G., Jacob H. S., Eaton J. W., Belcher J. D., Vercellotti G. M., Arterioscler. Thromb., 11, 1700-1711 (1991).
18. YLÄ-Herttuala S., Rosenfeld M. E., Parthasarathy S., Glass C. K., Sigal E., Witztum J. L., Steinberg D., Proc. Natl. Acad. Sci. U.S.A., 87, 6959-6963 (1990).
19. Daugherty A., Dunn J. L., Rateri D. L., Heinecke J. W., J. Clin. Invest., 94, 437-444 (1994).
20. Graham A., Hogg N., Kalyanaraman B., O'Leary V., Darley-Usmar V., Moncada S., FEBS Lett., 330, 181-185 (1993).